N/A
N=339
Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding
Gastrointestinal Bleeding
Bottom Line
View on ClinicalTrials.gov: NCT01821326 ↗Enrolled (actual)
339
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcome: Primary: Rebleeding Rate — 97 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Primary completion
- Jan 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rebleeding Rate |
97 | — |
Summary
The investigators investigated the rebleeding rate the risk factors for rebleeding after long-term follow-up (≥12 months) in patients who underwent capsule endoscopy for obscure gastrointestinal bleeding.
Eligibility Criteria
Inclusion Criteria
- Patients who underwent capsule endoscopy in Shanghai Renji Hospital(China) from June 2002 to January 2012 for obscure gastrointestinal bleeding
Exclusion Criteria
- patients who did not undergo a gastroscopy and colonoscopy performed before capsule endoscopy examination; and
- patients with follow-up examination for other know clinical diseases.
Data sourced from ClinicalTrials.gov (NCT01821326). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.